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Despite the South African antiretroviral therapy rollout, which should reduce the incidence of HIV-associated tuberculosis
(TB), the number of TB-attributable deaths in KwaZuluNatal (KZN) remains high. TB is often diagnosed clinically, without
microbiologic conﬁrmation, leading to inaccurate estimates of TB-attributed deaths. This may contribute to avoidable deaths,
and impact population-based TB mortality estimates. Objectives. (1) To measure the number of cases with microbiologically
conﬁrmed TB in a retrospective cohort of deceased inpatients with TB-attributed hospital deaths. (2) To estimate the rates of
multi-drug resistant (MDR) and extensively drug resistant (XDR) TB in this cohort. Results. Of 2752 deaths at EDH between
September 2006 and March 2007, 403 (15%) were attributed to TB on the death certiﬁcate. 176 of the TB-attributed deaths (44%)
had a specimen sent for smear or culture; only 64 (36%) had a TB diagnosis conﬁrmed by either test. Of the 39 culture-conﬁrmed
cases, 27/39 (69%) had fully susceptible TB and 27/39 (69%) had smear-negative culture-positive TB (SNTB). Two patients had
drug monoresistance, three patients had MDR-TB, and one had XDR-TB. Conclusions. Most TB-attributed deaths in this cohort
were not microbiologically conﬁrmed. Of conﬁrmed cases, most were smear-negative, culture positive and were susceptible to all
ﬁrst line drugs.
1.Introduction
Tuberculosis (TB) is a global problem, with approximately 9
million new cases per year; of these cases, 1.1 million cases
per year are due to coinfection with TB and human immun-
odeﬁciency virus (HIV) [1]. Approximately 82% of the glob-
al cases of HIV-associated TB are in the African Region, and
South Africa accounts for a signiﬁcant proportion of cases
in the region [1]. In 2010, South Africa had the third largest
absolute number of TB cases in the world, with an incidence
of 0.4–0.59 million [1], or 998 cases/100,000 population
[2]. 73% of new TB cases in South Africa in 2007 were
HIV positive [2]. Tuberculosis is the leading cause of death
in South Africa by clinically determined death notiﬁcation
forms [3]. Edendale Hospital (EDH) is an 860-bed district
and regional hospital in Pietermaritzburg, KwaZuluNatal
(KZN), South Africa, and is the regional TB referral centre.
It serves a mainly Black African population of approximately
1.6 million [4]. HIV prevalence rates in regional antenatal
clinics vary between 40 and 50% [5], and the rate of TB
disease in KZN is estimated as between 773–1008/100,000
[3]. The high TB mortality rate in this region is likely asso-
ciated with the high HIV prevalence and/or the presence
of drug-resistant TB known to be in the region. Recently,
an outbreak of XDR-TB (extensively drug-resistant TB) oc-
curred in a rural hospital approximately 100km from EDH
[6].Themediansurvivaltimeinthisoutbreakwastwoweeks
after obtaining sputum samples. Almost all of these patients
were HIV positive [6]. Information on the patients who died
indirectly or directly as a result of TB at EDH may reveal2 Clinical and Developmental Immunology
high proportions of speciﬁc patterns of drug resistance,
speciﬁcally MDR-TB (multidrug-resistant TB) and XDR-TB,
which are associated with high mortality. A recent post-
mortem study at EDH revealed that the accuracy of limited
autopsy diagnosis of TB is approximately 47%; furthermore,
42% of patients who died who previously were not suspected
to have TB were actually TB culture positive on limited au-
topsy [7]. The present study set out to measure the number
of patients with a TB diagnosis by sputum smear and culture
in TB-attributed hospital deaths and to estimate the rates of
MDR- and XDR-TB in TB-attributed hospital deaths.
2. Methods
A retrospective cohort study of all adult inpatients admitted
to the EDH wards that died with a diagnosis of TB during
a seven-month period between September 2006 and March
2007 was undertaken. A list from the EDH mortuary of
patients who died during the study period with a diagnosis
of TB recorded on their death certiﬁcate was recorded and
cross-referenced with the EDH laboratory AFB (acid fast
bacilli) smear registry and culture and drug susceptibility
registry. The study period was chosen due to the availability
of data from the hospital mortuary and mycobacteriology
laboratories.Physiciansﬁllingoutthedeathcertiﬁcatescould
include up to three diagnoses. Ethics approval for the audit
was obtained from the Edendale Hospital Ethics Committee.
One of the authors (T.I.Liu) collected and cross-referenced
the data manually. The mortuary lists of TB-attributed
deaths and the AFB smear registry were on paper. The TB
culture and susceptibility data was computerized, and was
accessed remotely through the mycobacteriology reference
laboratory at Inkosi Albert Luthuli Central Hospital.
3. Inclusion Criteria
All adult inpatients (>1 8y e a r so fa g e )a tE D Hw e r ee l i g i b l e
for inclusion in the study if they died in hospital during the
study period, and if TB was documented by a hospital phy-
sician on their death certiﬁcate as being a direct or indirect
cause of death. Death certiﬁcate data was only available from
the mortuary for patients who died on an adult inpatient
ward at EDH.
4. Deﬁnitions
AFB smear results were recorded as negative, scanty, 1+,
2+, or 3+, as deﬁned by the South African National TB
Control Programme Practical Guidelines [8]. Sputum sam-
ples are not routinely sent for culture in this resource limited
setting, unless the patient has been on TB treatment in the
past, is persistently smear-positive on treatment, or is per-
sistently symptomatic despite two previous negative smears
and a course of broad-spectrum antibiotics, or if recurrent/
relapsed TB disease is suspected [8]. Smear and culture
methodology are in accordance with international guidelines
using ﬂorescent microscopy, liquid media for initial culture,
and Middlebrook 7H10 solid media for drug susceptibility
Table 1: Clinical and demographic characteristics.
T o t a ln u m b e ro fT Bd e a t h s n = 403
Sex, female (%) 144 (36%)
Sex, male (%) 122 (30%)
Sex not documented on death certiﬁcate 137 (34%)
Average age at death, years (standard deviation) 36 (14)
Pulmonary TB (%) 227 (56%)







TB source unknown 58 (14%)
Documented HIV positive∗ 22 (5.4%)
Presumed HIV positive∗∗ 55 (13.6%)
HIV status unknown 326 (81%)
∗DocumentedHIVpositiveviaCD4orHIVviralloadrecords; ∗∗Presumed
HIV positive due to death certiﬁcate diagnosis of HIV, retroviral disease
(RVD), or AIDS-deﬁning opportunistic infection.
testing. Positive TB cultures that were sent for susceptibility
testing were classiﬁed as pansensitive to all ﬁrst line drugs,
monoresistant to a single agent, multidrug resistant (MDR),
or extensively drug resistant (XDR). MDR-TB is deﬁned as
resistance to at least isoniazid (INH) and rifampin (RIF).
XDR-TB is deﬁned as resistance to INH and RIF as well as
resistancetotheﬂuoroquinolonesandanyoneofthesecond-
line injectable antituberculous drugs (amikacin, kanamycin,
or capreomycin), as per the October 2006 revised deﬁnition
by the World Health Organization (WHO) Global XDR-TB
Task Force [9].
5. Results
5.1. Demographics. The average age at death was 36 years
(standarddeviation14).Approximatelyone-thirdofsubjects
were male, one-third was female, and for the remaining one-
third, gender was unavailable (Table 1).
5.2. In Hospital TB Deaths. Of 2752 inpatient deaths in the
seven-month study period from September 2006 to March
2007, 403 deaths (14.6%) were attributed to TB according to
the death certiﬁcate. An average of 58 TB deaths per month
occurred during the study period.
5.3. Site of Disease (Tables 1 and 2). Pulmonary TB (PTB)
was the most common site of infection, with 227/403 (56%)
cases (Tables 1 and 2). 118 (29%) had extrapulmonary TB
(EPTB). Meningitis, miliary/disseminated, and peritoneal
TB were the most common types of EPTB. 58 subjects (14%)
did not have a speciﬁc site of TB infection documented on
the death certiﬁcate and did not have any supportive AFB
smear or culture results to help identify disease site.Clinical and Developmental Immunology 3
Table 2: Number of TB-attributed inpatient deaths, by disease site and diagnostic test.














PTB 227 (56) 61 28 59 29 47 227 (56)
EPTB
Disseminated/miliary 30 (7.4) 11 1 9 4 5
TB meningitis 59 (14.6) 10 0 13 2 2
TB abdomen 20 (4.9) 3 1 7 1 1 118 (29)
TB spine 5 (1.2) 1 0 1 0 0
TB pericardium 1 (0.2) 0 0 1 0 0
TB source unknown 58 (14) 8 1 9 2 3 58 (14)



















































































Figure 1: Drug susceptibility proﬁle of positive cultures.
5.4. TB Culture and Susceptibility. 176/403 (44%) of the
patients had a result registered for AFB smear or culture, and
of those, only about 64/176 (36%) had a TB diagnosis con-
ﬁrmedwitheithertest(T able2).Ofthe39culture-conﬁrmed
cases, 27 (69%) were smear negative, of which 12 were spu-
tum samples, 7 lymph node or abscess aspirates, 6 pleural or
peritoneal ﬂuid samples, and 1 CSF sample. Of the 39 cul-
ture-conﬁrmed cases, 27/39 (69%) had fully susceptible TB
(Figure 1). Two patients had drug monoresistance, three
patients had MDR-TB, and one had XDR-TB. Six patients
(15.4%) had culture-positive TB with no susceptibility re-
sults available. Of the six cases of drug-resistant TB of any
kind, only two had been previously designated as MDR-
TB suspects (one had culture-conﬁrmed MDR-TB, and the
other had rifampin monoresistance). Of the ﬁfteen MDR-
TB suspects, only one patient had conﬁrmed MDR-TB. The
one case of XDR-TB was not previously suspected to have
had drug-resistant TB. In two patients, Mycobacteria other
than TB (MOTT) was isolated (one grew MOTT alone, and
another grew both TB and MOTT).
6. Discussion
The present study demonstrates that TB mortality remains
high in this region, and that the majority of patients that
died with a diagnosis of TB did not have a microbiologically
conﬁrmed diagnosis by AFB smear or culture. Of those with
a conﬁrmed diagnosis, the majority were smear negative,
culture positive, and susceptible to all ﬁrst line drugs; only
onecaseofXDR-TBwasidentiﬁed.Theﬁndingslikelyreﬂect
the known high prevalence of HIV in the region, which
has increased the SNTB rates resulting in diagnostic delays
in the community. Many HIV-positive patients have AFB
smear-negativeTBdisease,resultingindiagnosticdelays,and
worsening of their clinical condition to the point that they
require hospital admission. Following admission, conﬁrma-
tion of TB is further delayed by the inability to obtain an
adequate diagnostic specimen from moribund patients, the
patients’ inability to produce sputum, and the lack of avail-
ability of appropriate invasive diagnostics. Mycobacteria
cultures may not be sent on inpatients already established on
antituberculosis therapy at a primary care clinic and admit-
ted with a superimposed condition (such as community ac-
quiredpneumonia).Onceaspecimenisobtained,thetimeto
conﬁrmationofTBisfurtherdelayedbythetimerequiredfor
laboratory culture and sensitivity testing. All of these reasons
contribute to low rates of microbiologic conﬁrmation of a
clinical TB diagnosis in this setting.
In our cohort of 39 culture-conﬁrmed cases among all
TB-attributed deaths, 69% had isolates susceptible to all
ﬁrst-line drugs. Despite having eﬀective antituberculosis
medications, many people in this region are dying of pansus-
ceptible TB, most likely due to the diﬃculties encountered in
the diagnosis of TB in HIV-infected patients. HIV-infected
patients are less likely to have AFB smear-positive disease or
cavitaryTBandaremorelikelytohavedisseminatedorEPTB
[7]. In this study, the proportion of PTB (56%) to EPTB
(29%) cases was approximately 2:1. In a previous study at
EDH in 2001, a similar ratio of PTB to EPTB cases (65%
compared to 36%) was noted [4]. The expected ratio of PTB
t oE P T Bc a s e sr a n g e sf r o m5:1[ 10]t o9:1[ 1]; according to
the WHO 2011 Global Tuberculosis Control Report, in high
burden countries in 2010, the distribution of PTB:EPTB
cases was approximately 9:1 [1]. The disproportionately
high number of EPTB cases at EDH is likely due to high rates
of undiagnosed HIV/TB coinfection in admitted patients.
Out of ﬁfteen MDR suspects in our cohort, only one had
conﬁrmed MDR-TB. This ﬁnding underscores the fact that
MDR-TB and XDR-TB are diﬃcult to distinguish clinically
from pansusceptible TB disease, and therefore routine4 Clinical and Developmental Immunology
airborne infection control practices should be undertaken
in all admitted TB suspects, regardless of the suspicion of
drug resistance. However, given the TB burden and limited
resources in this part of the world, the logistics of infection
control remains a signiﬁcant challenge.
A recent postmortem study by Cohen et al. that was done
at EDH one year after the present study was completed
showed that in a representative sample of 240 inpatient
deaths between October 2008 and August 2009, 110 (47%)
were culture positive on limited autopsy pooled sampling of
respiratory tract secretions and core biopsies of lung, liver,
and spleen [7]. 121 of these inpatient deaths (50.4%) were
not on TB treatment at the time of death, and 119 (49.5%)
of them were on TB treatment [7]. Of those 119 cases on TB
treatment, 64 (58%) were culture positive, and 55 (46%)
were culture negative [7]. Therefore 55/240 (23%) of these
cases would have been attributed to TB in hospital deaths
basedonthedeathcertiﬁcate,intheabsenceofapositivecul-
ture result. In this study, which was done at the same center
as our study only one year later, the TB diagnosis rate (by
culture-positive limited autopsy samples) among TB sus-
pects was 58%, which demonstrates the signiﬁcant under-
estimation of TB hospital attributed deaths in this region
when using only the death certiﬁcate. The death certiﬁcate
diagnosis rate of TB at EDH was less accurate than limited
autopsy likely due to the challenges in obtaining sputum or
other tissue as outlined previously, as well as the high rates
of smear-negative TB associated with high HIV prevalence.
Most patients with culture-conﬁrmed TB had drug-sus-
ceptible TB, which was perhaps surprising giving the docu-
mented prevalence of MDR- and XDR-TB in this region of
South Africa [1]. A selection bias that may have aﬀected our
results is that admitted patients who died of TB may have
died immediately following admission, prior to appropriate
samples being sent for testing. Information on length of hos-
pital stay prior to death was not available for our subjects. A
selection bias could have resulted from these patients, since
they may have had a higher rate of resistance; it is known
thatpatientsinfectedwithXDR-TBhaveashortenedsurvival
[6] .Ar e c e n ts t u d yi nK Z Nd e m o n s t r a t e dm a r k e d l yh i g h
early mortality rates for HIV/drug-resistant TB coinfection;
40% of HIV/MDR-TB and 51% of HIV/XDR-TB cases died
within 30 days of sputum collection [11]. Because patients in
our study may have died rapidly after admission, they may
have been too debilitated to give an adequate sputum sample
for culture or undergo invasive testing. The selection bias
would apply to the 226 subjects that died without having a
specimen sent for AFB smear or culture; however these pa-
tients would have had the same random chance of having
either a sputum sample or another type of specimen sent to
the laboratory prior to admission. We would have expected
that patients that were at higher risk of resistance would
have had sputum sent for testing, as per the South African
National TB Control Program guidelines [8]. Furthermore,
patients infected with MDR- or XDR-TB may have died
before they even presented to hospital and thus would not
be accounted for in hospital mortality registries. From
the WHO 2011 Global Tuberculosis Control Report, an
estimated 1.8% of incident TB cases in South Africa were
MDR-TB [1]. In our study, from the 39 culture-conﬁrmed
TB deaths, we found 3 cases of MDR-TB and 1 case of XDR-
TB. Although we do not know the South African MDR-TB
mortality rate, this is in keeping with the published rates of
incident MDR-TB cases in South Africa [1].
Another limitation of our study is that we were not able
to determine the HIV status of the majority of our subjects
since at the time of the study point of care testing was not
available. It is well documented that HIV/TB coinfection
increases the rapidity of clinical deterioration and increases
the risk of death [12–15]. Stigma associated with HIV/AIDS
may inﬂuence people’s willingness to be tested for HIV—
“retroviral disease” was a common euphemism used on the
death certiﬁcates to avoid labeling patients as HIV positive.
Of the four patients with either MDR-TB or XDR-TB in our
study, three had documented HIV infection. EDH has since
developedaprograminwhichadesignatedteamoflayhealth
workersoﬀerpointofcareHIVtestingandassistinobtaining
sputum samples to all admitted TB suspect patients [16].
Future studies should focus on streamlining which patients
should get smears and cultures sent to the laboratory, given
the high number of specimens processed and the limited
resources of regional laboratories.
Misclassiﬁcation bias may have occurred in physician-
completed death certiﬁcates. All over the world, physicians
often have to make a judgment call on the ultimate cause of
death of the deceased. Determining the cause of death in
patients with active TB disease is a challenge and thus may
have resulted in misclassiﬁcation. A review of 60 cases of pul-
monary TB in a hospital in Manchester, Great Britain, in
1983, demonstrated that the actual cause of death in admit-
ted inpatients with TB can be diﬃcult to ascertain [17]. In
this study, the pulmonary TB in-hospital mortality rate over
a 7-year period (1974–1981) was 7%; of the 60-patients that
died, 36 died while on treatment for TB. 10 patients died
with unequivocal evidence of overwhelming tuberculosis
infection, 6 died for unrelated reasons, and 4 died of drug-
related conditions. The remaining 16 (27%) died suddenly
or unexpectedly for unclear reasons—13 of these patients
underwent autopsy, and 9 patients still did not have an iden-
tiﬁable cause of death on postmortem [17]. Despite autopsy,
there were still diﬃculties in identifying the actual cause
of death in patients with pulmonary TB. Verbal autopsies,
in which ﬁeldworkers interview close family members to
complete a questionnaire asking about a patient’s symptoms
and course of illness prior to their death, have been validated
as a useful tool in South Africa [18, 19]. In a study looking
at mortality in South African gold miners with pulmonary
TB, the cause of death was determined by reviewing clinical
records and from the results of limited autopsies of the
heart and lungs [14]. In this population, limited autopsies
are mandated for purposes of compensation but have also
provided further information on patterns of TB disease and
drug susceptibility in South Africa.
7. Conclusions
Our study demonstrates that hospitalized TB patients con-
tinue to experience a high mortality, despite major eﬀorts toClinical and Developmental Immunology 5
roll out antiretrovirals (ARVs) in this high HIV prevalence
region, and that the majority of patients that died with TB
identiﬁed as the cause of death on the death certiﬁcate did
not have a TB diagnosis conﬁrmed by AFB smear or culture.
The majority of the TB suspects that were tested for and died
of TB had a fully susceptible organism. The cohort studied
detected only one XDR-TB case, despite signiﬁcant XDR-
TB outbreaks associated with high mortality in a nearby
hospital. Death certiﬁcate diagnosis of TB was less accurate
than limited autopsy diagnosis of TB at the same hospital,
during a similar time period.
8.Lessons Learned
This study emphasizes the importance of active TB and HIV
case ﬁnding among inpatients at EDH, such as through
the work of EDH’s “TB Warriors” program in coordinating
laboratory testing treatment and follow-up of TB suspects
[16]. In this area of high HIV endemicity, routine testing
f o rH I Vs h o u l dc o n t i n u et ob eo ﬀered to TB patients to help
identify more HIV/TB coinfected people, who are at higher
risk of dying. Diagnosing TB quickly and eﬃciently in this
setting continues to be a challenge given the high prevalence
of both TB and HIV, but it is limited by hospital and labo-
ratory resources. There is also an urgent need for diagnostic
tools that will rapidly diagnose TB in patients too ill to
produce sputum. Clinicians should have a low threshold for
sending sputum for TB culture in HIV positive patients,
given the greater possibility of smear negative and/or drug-
resistant TB. The earlier patients are diagnosed, the greater
chance of starting both TB and HIV treatment in a timely
fashion, thus reducing HIV/TB-associated mortality.
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